PT  - JOURNAL ARTICLE
AU  - Röthlin Eriksen, Alexandra R
AU  - Fogh, Kamille
AU  - Hasselbalch, Rasmus B
AU  - Bundgaard, Henning
AU  - Nielsen, Susanne D
AU  - Jørgensen, Charlotte S
AU  - Scharff, Bibi FSS
AU  - Erikstrup, Christian
AU  - Sækmose, Susanne G.
AU  - Holm, Dorte K
AU  - Aagaard, Bitten
AU  - Kristensen, Jonas H
AU  - Bødker, Cecilie A
AU  - Norsk, Jakob
AU  - Nielsen, Pernille Brok
AU  - Østergaard, Lars
AU  - Ellermann-Eriksen, Svend
AU  - Andersen, Berit
AU  - Nielsen, Henrik
AU  - Johansen, Isik S.
AU  - Wiese, Lothar
AU  - Simonsen, Lone
AU  - K.Fischer, Thea
AU  - Folke, Fredrik
AU  - Lippert, Freddy
AU  - Ostrowski, Sisse R
AU  - Ethelberg, Steen
AU  - Koch, Anders
AU  - Vangsted, Anne-Marie
AU  - Krause, Tyra
AU  - Fomsgaard, Anders
AU  - Nielsen, Claus
AU  - Ullum, Henrik
AU  - Skov, Robert
AU  - Iversen, Kasper
TI  - SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study
AID  - 10.1101/2021.05.07.21256388
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.07.21256388
4099  - http://medrxiv.org/content/early/2021/05/12/2021.05.07.21256388.short
4100  - http://medrxiv.org/content/early/2021/05/12/2021.05.07.21256388.full
AB  - Background People experiencing homelessness (PEH) and associated shelter workers may be at higher risk of infection with “Severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2). The aim of this study was to determine the prevalence of SARS-CoV-2 among PEH and shelter workers in Denmark.Design and methods In November 2020, we conducted a nationwide cross-sectional seroprevalence study among PEH and shelter workers at 21 recruitment sites in Denmark. The assessment included a point-of-care test for antibodies against SARS-CoV-2, followed by a questionnaire. The seroprevalence was compared to that of geographically matched blood donors considered as a proxy for the background population, tested using a total Ig ELISA assay.Results We included 827 participants in the study, of whom 819 provided their SARS-CoV-2 antibody results. Of those, 628 were PEH (median age 50.8 (IQR 40.9-59.1) years, 35.5% female) and 191 were shelter workers (median age 46.6 (IQR 36.1-55.0) years and 74.5% female). The overall seroprevalence was 6.7% and was similar among PEH and shelter workers (6.8% vs 6.3%, p=0.87); and 12.2% among all participants who engaged in sex work. The overall participant seroprevalence was significantly higher than that of the background population (2.9%, p <0.001). When combining all participants who reported sex work or were recruited at designated safe havens, we found a significantly increased risk of seropositivity compared to other participants (RR 2.1, 95% CI 1.16-3.75, p=0.02). Seropositive and seronegative participants reported a similar presence of at least one SARS-CoV-2 associated symptom (49% and 54%, respectively).Interpretations The prevalence of SARS-CoV-2 antibodies was more than twice as high among PEH and associated shelter workers, compared to the background population. The subset of the study participants who were also sex workers were at particularly high risk of COVID-19 infection.Funding TrygFonden and HelseFonden.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from the foundations of TrygFonden [152144] and HelseFonden [20-A-0124]. The funders did not influence study design, conduct or reporting.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was performed as a national surveillance study under the authority task of Statens Serum Institut (SSI; Copenhagen, Denmark, the Danish National Institute for Infectious Disease Control and Prevention which performs the epidemiological surveillance of infectious diseases for the Danish government), hence does not require any formal approval from an ethics committee according to Danish law. This decision was made by the regional Ethics Committee of the Capital Region in Denmark (20057075). This study was carried out in agreement with the Helsinki II declaration. All participation in this study was voluntary. This study was registered with the Danish Data Protection Authorities (P-2020-901). All personal data, obtained in REDCap, was kept in accordance with the general data protection regulation and data protection law stated by the Danish Data Protection Agency.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data are available